Posted by
Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis

Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis

Summary Background Medicinal cannabinoids, including medicinal cannabis and pharmaceutical cannabinoids and their synthetic derivatives, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), have been suggested to have a therapeutic role in certain mental disorders. We analysed the available evidence to ascertain the effectiveness and safety of all types of medicinal cannabinoids in treating symptoms of various […]

Posted by
Comparing ECT and TMS Treatments for Depression

Comparing ECT and TMS Treatments for Depression

The road to recovery for depression patients is seldom clear or straightforward. The first line of defense, typically a combination of antidepressants and psychotherapy, may prove ineffective or too fraught with side effects to be helpful. Fortunately, alternatives are available for those dealing with more extreme or treatment-resistant varieties of this disorder. In cases of […]

Posted by
Ketamine and Future Depression Treatments

Ketamine and Future Depression Treatments

Researchers are hailing ketamine as the most significant new development in psychiatry given its high efficacy for treating major depression. Recent evidence has shown that in addition to depression, ketamine may also be a promising treatment for obsessive-compulsive disorder, post-traumatic stress disorder, and a number of other treatment-refractory neuropsychiatric disorders. In a recent paper published in Drug Discovery […]

Posted by
FDA warns company marketing unapproved cannabidiol products with unsubstantiated claims to treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety

FDA warns company marketing unapproved cannabidiol products with unsubstantiated claims to treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety

Agency is expediting work to evaluate regulatory policies related to cannabis and cannabis-derived ingredients like CBD Today, the U.S. Food and Drug Administration announced that it has issued a warning letter to Curaleaf Inc., of Wakefield, Massachusetts, for illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid […]

Posted by
The Effects of Chronic Stress On Your Mental Wellness

The Effects of Chronic Stress On Your Mental Wellness

Let’s face it: we’re all stressed these days. In fact, recent polls show just how stressed out Americans are over things like politics, work, finances … the list goes on and on. It seems like we’ve adopted a new work culture where the 8-hour workday is a thing of the past. People are working 9 […]

Posted by
Flashing Lights and Odd-Ball Beeps: The Tools that Help PASWFL Map and Treat Depression

Flashing Lights and Odd-Ball Beeps: The Tools that Help PASWFL Map and Treat Depression

Quantitative Electroencephalograms (QEEG’s) Help us ‘See’ Depression QEEGs have allowed us to repurpose existing neurological tests to help us better diagnose and treat major depressive, and related, disorders. Until now, we have bolstered a solid history and mental status examination with direct patient queries, objective written tests and scales. Technology and neurochemistry have given us […]

Posted by
AMA: Do Not Use Electronic Cigarettes

AMA: Do Not Use Electronic Cigarettes

HealthDay News – Americans should not use electronic cigarettes while health officials investigate cases of severe lung illness that may be linked to the devices, according to a statement issued by Patrice A. Harris, MD, president of the American Medical Association. “In light of increasing reports of e-cigarette-associated lung illnesses across the country, the AMA […]

Posted by
Unlocking the Mysteries of the Glutamate System

Unlocking the Mysteries of the Glutamate System

Ketamine, Similar Compounds Emerging as Mood Disorder Treatments Sanjay J. Mathew, MD, vice chair for research at Baylor College of Medicine and staff physician at the Michael E. Debakey VA Medical Center in Houston, Texas, has long been interested in the brain’s glutamate system and how it could be manipulated with substances such as ketamine to […]